Abstract:What's new? Greater body fatness and adult weight gain are established risk factors for postmenopausal breast cancer, but the impact of excess body weight on breast cancer outcomes remains unclear. In this systematic review and meta‐analysis of the Global Cancer Update Program, the independent expert panel concluded that there was strong evidence (likelihood of causality: probable) that postdiagnosis body fatness increases the risks of all‐cause mortality, breast cancer‐specific mortality and second primary breast cancer in women diagnosed with breast cancer. The findings support the development of lifestyle recommendations for breast cancer survivors to avoid obesity and be physically active, within the limits of their ability and specific medical advice. Previous evidence on postdiagnosis body fatness and mortality after breast cancer was graded as limited‐suggestive. To evaluate the evidence on body mass index (BMI), waist circumference, waist‐hip‐ratio and weight change in relation to breast cancer prognosis, an updated systematic review was conducted. PubMed and Embase were searched for relevant studies published up to 31 October, 2021. Random‐effects meta‐analyses were conducted to estimate summary relative risks (RRs). The evidence was judged by an independent Expert Panel using pre‐defined grading criteria. One randomized controlled trial and 225 observational studies were reviewed (220 publications). There was strong evidence (likelihood of causality: probable) that higher postdiagnosis BMI was associated with increased all‐cause mortality (64 studies, 32 507 deaths), breast cancer‐specific mortality (39 studies, 14 106 deaths) and second primary breast cancer (11 studies, 5248 events). The respective summary RRs and 95% confidence intervals per 5 kg/m2 BMI were 1.07 (1.05‐1.10), 1.10 (1.06‐1.14) and 1.14 (1.04‐1.26), with high between‐study heterogeneity (I2 = 56%, 60%, 66%), but generally consistent positive associations. Positive associations were also observed for waist circumference, waist‐hip‐ratio and all‐cause and breast cancer‐specific mortality. There was limited‐suggestive evidence that postdiagnosis BMI was associated with higher risk of recurrence, nonbreast cancer deaths and cardiovascular deaths. The evidence for postdiagnosis (unexplained) weight or BMI change and all outcomes was graded as limited‐no conclusion. The RCT showed potential beneficial effect of intentional weight loss on disease‐free‐survival, but more intervention trials and well‐designed observational studies in diverse populations are needed to elucidate the impact of body composition and their changes on breast cancer outcomes.

A comparative analysis of risk factor associations with interval and screen‐detected breast cancers: A large UK prospective study

Severity and risk factors of interval breast cancer in Queensland, Australia: a population-based study

Breast density effect on the sensitivity of digital screening mammography in a UK cohort

Trajectories in mammographic breast screening participation in middle-age overweight and obese women: A retrospective cohort study using linked data

[Female lung cancer trends, staging and histology in Hérault, France].

Radiological features of screening-detected and interval breast cancers and subsequent survival in Eastern Finnish women

Age-specific differences in tumour characteristics between screen-detected and non-screen-detected breast cancers in women aged 40–74 at diagnosis in Sweden from 2008 to 2017

First UK National Data Reveal More Breast Cancers Between Screenings Than Expected

Atypia detected during breast screening and subsequent development of cancer: observational analysis of the Sloane atypia prospective cohort in England

The Pathology of Experimental Aerosolized Monkeypox Virus Infection in Cynomolgus Monkeys (Macaca fascicularis)

AutoDunt: Dynamic Latent Dependence Analysis for Detection of Zero Day Vulnerability

Postdiagnosis body fatness, weight change and breast cancer prognosis: Global Cancer Update Program (CUP global) systematic literature review and meta‐analysis

Molecular characteristics of screen-detected vs symptomatic breast cancers and their impact on survival

The influence of breast screening on breast cancer incidence in England: observational study based on cancer registries and bulletins of the NHS Breast Screening Programme

The impact of height and weight on rescreening rates within a population‐based breast screening program

Breast cancer stage and size detected with film versus digital mammography in New South Wales, Australia: a population-based study using routinely collected data

Abstract 4850: Sex differences in cancer incidence: Prospective analyses in the UK Biobank

Removal of radial-artery thrombi following percutaneous cannulation for monitoring.

[Prospects for the development of an anti-adhesive vaccine against strains of Escherichia coli causing diarrhea in humans (3)].

Age-specific differences in breast cancer treatment between screen-detected and non-screen-detected breast cancers in women aged 40–74 years at diagnosis in Sweden 2008–2017

Percentage mammographic density or absolute breast density for risk stratification in breast screening: Possible implications for socioeconomic health disparity